Generated Narrative: ResearchStudy JPMA0001-eng

Language: en

Profile: M11 Research Study Profile

M11 Research Study Extension

  • originalProtocol: Protocol Not Amended
  • versionDate: 2026-01-14

identifier: Sponsor Identifier/JPMA001 (use: usual, )

version: 2.0

title: A Multicenter, 52-week, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Co-administration of JPMA001 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control Treated With Oral Hypoglycemic Drugs as a Single Agent

Labels

-TypeValue
*Short titleAdministration for patients with type 2 diabetes

date: 2026-01-14

status: Active

phase: Phase III Trial

 <label> <type> <coding> <system value="http://hl7.org/fhir/title-type"/> <code value="short-title"/> <display value="Short title"/> </coding> </type> <value value="Administration for patients with type 2 diabetes"/> </label> <date value="2026-01-14"/> <status value="active"/> <phase> <coding> <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/> <code value="C15602"/> <display value="Phase III Trial"/> </coding> </phase> </ResearchStudy>